Canagliflozin vs Trastuzumab

Canagliflozin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Canagliflozin and Trastuzumab.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S.

Molecular Weight: Canagliflozin — 444.5170 g/mol.

Type: Canagliflozin — Small molecule; Trastuzumab — Antibody.